Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias

Autor: Matthew R.G. Taylor, Ernesto E. Salcedo, Giulia Barbati, Frank I. Marcus, Luisa Mestroni, Dobromir Slavov, Sharon L. Graw, Jeffrey A. Towbin, Gianfranco Sinagra, Marco Merlo, Francesca Brun, Andrea Di Lenarda, Jeffrey E. Saffitz, Wojciech Zareba, Anita Spezzacatene
Přispěvatelé: Spezzacatene, Anita, Sinagra, Gianfranco, Merlo, Marco, Barbati, Giulia, Graw, S. L., Brun, F., Slavov, D., DI LENARDA, Andrea, Salcedo, E. E., Towbin, J. A., Saffitz, J. E., Marcus, F. I., Zareba, W., Taylor, M. R. G., Mestroni, Luisa
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Male
Time Factors
medicine.medical_treatment
Cardiomyopathy
Kaplan-Meier Estimate
030204 cardiovascular system & hematology
Ventricular tachycardia
Severity of Illness Index
Sudden cardiac death
0302 clinical medicine
Risk Factors
Cause of Death
Prevalence
Registries
030212 general & internal medicine
Original Research
Heart transplantation
arrhythmia
cardiomyopathy
prognosis
sudden death
Dilated cardiomyopathy
Middle Aged
musculoskeletal system
3. Good health
Phenotype
Disease Progression
Cardiology
cardiovascular system
Female
Cardiology and Cardiovascular Medicine
prognosi
Adult
Cardiomyopathy
Dilated

medicine.medical_specialty
complex mixtures
Sudden death
Disease-Free Survival
03 medical and health sciences
Internal medicine
medicine
Humans
cardiovascular diseases
business.industry
Arrhythmias
Cardiac

medicine.disease
Death
Sudden
Cardiac

Heart failure
Ventricular fibrillation
Electrocardiography
Ambulatory

Heart Transplantation
business
Zdroj: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Popis: Background Patients with dilated cardiomyopathy ( DCM ) may present with ventricular arrhythmias early in the disease course, unrelated to the severity of left ventricular dysfunction. These patients may be classified as having an arrhythmogenic DCM ( AR ‐ DCM ). We investigated the phenotype and natural history of patients with AR ‐ DCM . Methods and Results Two hundred eighty‐five patients with a recent diagnosis of DCM (median duration of the disease 1 month, range 0 to 7 months) and who had Holter monitoring at baseline were comprehensively evaluated and followed for 107 months (range 29 to 170 months). AR ‐ DCM was defined by the presence of ≥1 of the following: unexplained syncope, rapid nonsustained ventricular tachycardia (≥5 beats, ≥150 bpm), ≥1000 premature ventricular contractions/24 hours, and ≥50 ventricular couplets/24 hours, in the absence of overt heart failure. The primary end points were sudden cardiac death ( SCD ), sustained ventricular tachycardia ( SVT ), or ventricular fibrillation ( VF ). The secondary end points were death from congestive heart failure or heart transplantation. Of the 285 patients, 109 (38.2%) met criteria for AR ‐ DCM phenotype. AR ‐ DCM subjects had a higher incidence of SCD / SVT / VF compared with non– AR ‐ DCM patients (30.3% vs 17.6%, P =0.022), with no difference in the secondary end points. A family history of SCD / SVT / VF and the AR ‐ DCM phenotype were statistically significant and cumulative predictors of SCD / SVT / VF . Conclusions One‐third of DCM patients may have an arrhythmogenic phenotype associated with increased risk of arrhythmias during follow‐up. A family history of ventricular arrhythmias in DCM predicts a poor prognosis and increased risk of SCD .
Databáze: OpenAIRE